Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Resmed Inc (RMD.AX)

Resmed Inc (RMD.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Resmed Inc 9001 Spectrum Center Boulevard San Diego CA 92123 USA

https://www.resmed.com P: 858-836-5000

Description:

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Key Statistics

Overview:

Market Capitalization, $K 42,006,493
Shares Outstanding, K 1,470,889
Annual Sales, $ 4,223 M
Annual Net Income, $ 897,556 K
Last Quarter Sales, $ 1,163 M
Last Quarter Net Income, $ 208,800 K
% of Institutional Shareholders 9.97%

Growth:

1-Year Return -16.09%
3-Year Return 9.82%
5-Year Return 76.75%
5-Year Revenue Growth 12.53%
5-Year Earnings Growth 22.70%
5-Year Dividend Growth 4.72%

Per-Share Information:

Most Recent Earnings 0.14 on 01/25/24
Latest Earnings Date N/A
Earnings Per Share ttm 0.60
EPS Growth vs. Prev Qtr -4.70%
EPS Growth vs. Prev Year 0.15%
Annual Dividend Rate, $ 0.18
Annual Dividend Yield 1.01%
Most Recent Dividend 0.048 on 02/07/24
Next Ex-Dividends Date 02/07/24
Dividend Payable Date 03/14/24
Dividend Payout Ratio 30.46%
Most Recent Split 2-1 on 08/12/10

RMD.AX Ratios

Ratio
Price/Earnings ttm 30.69
Price/Earnings forward 23.26
Return-on-Equity % 21.66%
Return-on-Assets % 13.11%
Profit Margin % 21.25%
Debt/Equity 0.37
Price/Sales 6.07
Price/Book 6.08
Book Value/Share 4.72
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar